Patents

Process patent

Seegpharm, has been granted in USA
Patent Number: US 9,845,289,B2
Date of Patent: Dec. 19, 2017
Covering Process for the synthesis of Dapsone and its intermediates.

The patent is currently being extended in the rest of the Geographical European Union.

Seegpharm under Patent Cooperation Treaty (PCT) application is currently extending the patent covering Process for the synthesis of Dapsone and its intermediates in selected countries in the rest of the world.

Product not available in countries covered by patents in force.